Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,290 | 246 | 84.3% |
| Consulting Fee | $1,500 | 1 | 13.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $226.40 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $1,874 | 14 | $0 (2022) |
| iCAD, Inc | $1,646 | 2 | $0 (2021) |
| GENZYME CORPORATION | $1,085 | 39 | $0 (2024) |
| Galderma Laboratories, L.P. | $471.79 | 17 | $0 (2024) |
| ABBVIE INC. | $444.58 | 21 | $0 (2024) |
| LEO Pharma Inc. | $433.58 | 17 | $0 (2024) |
| Amgen Inc. | $421.03 | 10 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $410.06 | 14 | $0 (2024) |
| Incyte Corporation | $364.04 | 9 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $344.83 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,292 | 44 | GENZYME CORPORATION ($325.08) |
| 2023 | $1,376 | 49 | GENZYME CORPORATION ($356.34) |
| 2022 | $1,625 | 50 | EPI Health, LLC ($327.80) |
| 2021 | $2,009 | 20 | iCAD, Inc ($1,646) |
| 2020 | $240.10 | 8 | Sun Pharmaceutical Industries Inc. ($134.04) |
| 2019 | $1,204 | 30 | PruGen, Inc. Pharmaceuticals ($289.69) |
| 2018 | $787.75 | 18 | Genentech USA, Inc. ($169.93) |
| 2017 | $2,483 | 30 | Allergan Inc. ($1,740) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: DERMATOLOGY | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Immunology | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: Immunology | ||||||
| 10/07/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: DERMATOLOGY | ||||||
| 10/04/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.95 | General |
| Category: Dermatology | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Dermatology | ||||||
| 09/10/2024 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Other Advanced Wound Management | ||||||
| 09/09/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.31 | General |
| 08/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Dermatology | ||||||
| 08/02/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $2.76 | General |
| Category: Dermatology | ||||||
| 07/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.38 | General |
| Category: Immunology | ||||||
| 07/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: IMMUNOLOGY | ||||||
| 05/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Immunology | ||||||
| 05/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: DERMATOLOGY | ||||||
| 05/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Immunology | ||||||
| 04/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $49.09 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,606 | 7,651 | $762,265 | $312,738 |
| 2022 | 26 | 3,728 | 7,454 | $806,219 | $343,144 |
| 2021 | 23 | 3,159 | 6,926 | $624,915 | $344,307 |
| 2020 | 19 | 2,474 | 5,718 | $456,325 | $232,417 |
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 319 | 437 | $86,889 | $39,174 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 417 | 529 | $79,363 | $37,518 | 47.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 487 | 795 | $75,383 | $36,913 | 49.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 366 | 513 | $91,160 | $33,918 | 37.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 513 | 839 | $96,873 | $31,454 | 32.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 386 | 748 | $100,980 | $22,358 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 153 | 182 | $38,507 | $18,937 | 49.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 402 | 2,883 | $33,949 | $15,861 | 46.7% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 22 | 25 | $29,109 | $15,093 | 51.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 64 | 83 | $24,219 | $12,008 | 49.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 56 | 86 | $22,015 | $10,795 | 49.0% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 13 | 22 | $15,656 | $8,120 | 51.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 130 | 190 | $16,627 | $7,976 | 48.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 28 | 32 | $9,829 | $4,775 | 48.6% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 16 | 16 | $7,324 | $3,413 | 46.6% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 24 | 24 | $5,159 | $2,507 | 48.6% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 19 | 22 | $5,315 | $2,465 | 46.4% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 20 | 20 | $4,616 | $2,047 | 44.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 42 | 52 | $5,091 | $1,827 | 35.9% |
| 67810 | Biopsy of eyelid | Office | 2023 | 11 | 11 | $3,567 | $1,721 | 48.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,594 | $1,244 | 48.0% |
| 69100 | Biopsy of ear | Office | 2023 | 18 | 20 | $3,335 | $1,184 | 35.5% |
| 17260 | Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | Office | 2023 | 12 | 13 | $2,230 | $1,067 | 47.8% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 27 | 29 | $2,224 | $310.36 | 14.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 47 | 66 | $253.19 | $54.84 | 21.7% |
About Dr. Michael Bastien, MD
Dr. Michael Bastien, MD is a Specialist healthcare provider based in Westlake Village, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053371096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bastien, MD has received a total of $11,016 in payments from pharmaceutical and medical device companies, with $1,292 received in 2024. These payments were reported across 249 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($9,290).
As a Medicare-enrolled provider, Bastien has provided services to 12,967 Medicare beneficiaries, totaling 27,749 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Westlake Village, CA
- Active Since 03/24/2006
- Last Updated 08/30/2010
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1053371096
Products in Payments
- RHOFADE (Drug) $1,705
- AXXENT SURFACE CONTROLLER (Device) $1,646
- DUPIXENT (Biological) $1,000
- Otezla (Drug) $421.03
- OPZELURA (Drug) $364.04
- SKYRIZI (Biological) $333.28
- EUCRISA (Drug) $315.65
- Zoryve (Drug) $264.76
- WYNZORA (Drug) $226.40
- Erivedge (Biological) $222.66
- ADBRY (Biological) $215.57
- TALTZ (Drug) $196.40
- LIBTAYO (Biological) $195.30
- Tremfya (Drug) $160.60
- EPIDUO FORTE (Drug) $158.49
- SOOLANTRA (Drug) $150.71
- XEOMIN (Biological) $150.17
- Sotyktu (Drug) $142.45
- PICATO (Drug) $139.18
- Winlevi (Drug) $130.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Westlake Village
Stephen Gomberg, M.d, M.D
Specialist — Payments: $8,852
Thomas Kim, Md, MD
Specialist — Payments: $6,455
Gary Carlson, Md, MD
Specialist — Payments: $5,965
Randolph Capri, Md, MD
Specialist — Payments: $5,656
Dr. John Darin, M.d, M.D
Specialist — Payments: $1,086
Dr. Glenn Cohen, M.d, M.D
Specialist — Payments: $49.19